Skip to main content

Table 1 Baseline characteristics of patients

From: Prevalence of different patterns of dyslipidemia in patients with type 2 diabetes in an Iranian population

  

Total

Women

Men

Age (years)

 

57.73 ± 10.59 a

56.88 ± 10.01

59.03 ± 11.29

The duration of diabetes (years)

 

8.70 ± 7.54

9.02 ± 7.70

8.27 ± 7.31

WC (cm)

 

96.26 ± 11.71

96.45 ± 12.29

96.01 ± 10.78

BMI (Kg/m2)

 

28.55 ± 4.79

29.58 ± 5.01

27.30 ± 4.57

SBP (mmHg)

 

131.84 ± 20.66

131.68 ± 21.10

132.18 ± 20.64

DBP (mmHg)

 

78.86 ± 12.11

78.91 ± 12.83

78.83 ± 12.22

FBS (mg/dL)

 

180.30 ± 73.02

179.96 ± 73.63

180.51 ± 72.00

HbA1C (%)

 

8.17 ± 1.85

8.13 ± 1.79

8.22 ± 1.93

2hPP (mg/dL)

 

244.35 ± 100.21

238.24 ± 98.02

252.41 ± 103.08

Creatinine (mg/dl)

 

1.01 ± 0.29

0.94 ± 0.26

1.11 ± 0.31

TG

≥150 mg/dl

957(45.6%) b

600(48.6%)

357(41.4%)*

TG

≥200 mg/dl

554(26.4%)

337(27.3%)

217(25.2%)

LDL

≥70 mg/dl

1679(80.1%)

1011(81.9%)

668(77.5%)*

LDL

≥100 mg/dl

877(41.8%)

538(43.6%)

339(39.3%)

HDL

(<40 mg/dl M & <50 mg/dl W)

1217(58.0%)

834(67.5%)

383(44.5%)

non-HDL

≥130 mg/dl

894(42.6%)

553(44.8%)

341(39.6%)*

AIP

>0.24

1845(88.0%)

1084(87.8%)

761(88.3%)

  1. aData are mean ± SD in 2097 patients with type 2 diabetes mellitus
  2. bData are number of patients (prevalence %)
  3. *p-value < 0.05
  4. WC:waist circumference; BMI:body mass index; SBP:systolic blood pressure; DBP:diastolic blood pressure; FBS:fast blood sugar; HbA1C: hemoglobin A1C; 2hPP:2-hour postprandial; TG: triglyceride; LDL: low-density lipoprotein; HDL: high-density lipoprotein; non-HDL: non-high-density lipoprotein (Total cholesterol minus HDL-C); AIP: atherogenic index of plasma (log (TG/HDL-C))